Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FQV7U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $98,266
Award facts
- Contract value 100% obligated
- $98,265.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., on January 30, 2026, for the supply of RINVOQ ER 30 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract is valued at $98,265.84 and carries a firm fixed-price structure, with an ultimate completion date of February 2, 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026, which authorizes the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems globally.
AmerisourceBergen serves as a critical pharmaceutical distributor for federal military and veteran healthcare programs, leveraging its established supply chain capabilities to fulfill recurring medical commodity needs across multiple therapeutic domains. The DLA Troop Support Medical contracts represent a strategic approach to ensuring consistent, reliable access to both specialty and generic pharmaceuticals, vaccines, and related medical supplies for the Defense Health Agency and other federal healthcare entities. AmerisourceBergen's selection reflects its demonstrated competency in managing complex federal pharmaceutical procurement and its capacity to meet stringent government requirements for medication sourcing and delivery.
Quick answers
Who was awarded contract SPE2DR26FQV7U?
SPE2DR26FQV7U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FQV7U worth?
The government has obligated $98,266 on SPE2DR26FQV7U.
Is contract SPE2DR26FQV7U an order under another contract?
Yes. SPE2DR26FQV7U is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV7U competed?
The extent of competition for SPE2DR26FQV7U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award